A. Case scenario one: back pain n = 33 | |||||
---|---|---|---|---|---|
Symptom-related information items | Results obtained (information gathered) | Medication-related information items | Results obtained (information provided) | ||
Self-reported survey n (%) | Simulated clients visit n (%) | Self-reported survey: n (%) | Simulated clients visit n (%) | ||
Duration of symptoms | 26(78.8) | 15(45.5) | Name of the medication | 11(33.3) | 11(34.4) |
Frequency of symptoms | 21(63.6) | 18(54.5) | Purpose of medication | 23(69.7) | 15(46.9) |
Comorbidity | 20(60.6) | 9(27.3) | Dosage form | 10(30.3) | 10(31.3) |
Age of the woman | 15(45.5) | 4(12.1) | Dose | 20(60.6) | 15(46.9) |
Gestational age | 29(87.9) | 19(57.6) | How to use the medication | 30(90.9) | 22(68.8) |
Weight of the woman | 10(30.3) | 3(9.1) | Duration of use | 27(81.8) | 18(56.3) |
Previous medical conditions | 23(69.7) | 11(33.3) | Side effect | 23(69.7) | 3(9.4) |
Previous medication history and current medication, allergy Hx | 16(48.5) | 6(18.2) | Drug interaction | 21(63.6) | 1(3.1) |
Importance of adherence | 25(75.8) | 4(12.5) | |||
Storage conditions | 27(81.8) | 1(3.1) |
B. Case scenario two: nausea and vomiting n = 33 | |||||
---|---|---|---|---|---|
Symptom-related information gathering | Self-reported survey | Simulated client visit | Medication-related information provision | Self-reported survey | Simulated client visit |
Duration of symptoms | 29(87.9) | 23(69.7) | Name of the medication | 12(36.4) | 10(31.3) |
Frequency of symptoms | 22(66.7) | 19(57.6) | Purpose of medication | 25(75.8) | 18(56.3) |
Comorbidity | 21(63.6) | 3(9.1) | Dosage form | 11(33.3) | 7(21.9) |
Age of the woman | 11(33.3) | 0(0.0) | Dose | 26(78.8) | 13(40.6) |
Gestational age | 27(81.8) | 22(66.7) | How to use the medication | 31(93.9) | 16(50.0) |
Weight of the woman | 7(21.2) | 1(3.0) | Duration of use | 24(72.4) | 17(53.1) |
Previous medical conditions | 22(66.7) | 11(33.3) | Side effect | 18(54.5) | 1(3.1) |
Previous medication history and current medication, allergy | 22(66.7) | 3(9.1) | Drug interaction | 20(60.6) | 2(6.3) |
Importance of adherence | 24(72.7) | 2(6.3) | |||
Storage conditions | 22(66.7) | 1(3.1) |